New research by scientists at the Lewis Katz School of Medicine at Temple University (LKSOM), including by lead investigator Shuxin Li, MD, PhD, Associate Professor at Shriners Hospital’s Pediatric Research Center and the Department of Anatomy and Cell Biology at LKSOM, indicates that neuron regeneration limitation may be overcome by targeting the liver kinase B1 (LKB1) protein. In mice with spinal cord injuries, targeting LKB1 stimulated long-distance neuron regeneration and led to gains in functional recovery. The report was published online in the journal Molecular Therapy, and coverage was provided by Rehab Management, Bioengineer.org, Scienmag, Medical Xpress, Health Medicine Network, Technology Networks and News-Medical.Net.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH
Related News
Major Advances in Treating Lung Blood Clots Could Eliminate Need for ICU Stay, According to New Research at the Lewis Katz School of Medicine at Temple University
Posted November 22, 2024A novel “on-the-table” therapeutic strategy with a total procedure time of less than one hour can safely reduce the size of blood clots lodged in the pulmonary arteries and eliminate the need for post-procedural drug infusion in an intensive care unit, according to Katz School of Medicine research.
Read MoreHealio Highlights Dr. Kristin Criner’s Session at the GOLD International COPD Conference
Posted November 21, 2024Healio highlighted the key takeaways from Dr. Criner’s session on how to identify and treat patients with COPD plus diabetes or osteoporosis.
Read More